Skip to McMaster Navigation Skip to Site Navigation Skip to main content

Antimicrobial Resistance Research

Developing new solutions for
ANTIBIOTIC RESISTANCE

Researchers at McMaster University are using generative AI, data science and advanced computing to drastically speed up drug discovery — and even design brand-new antibiotics.

McMaster University’s Jon Stokes has been named one of Canada’s Top 40 Under 40® for 2026, a recognition that celebrates exceptional young leaders who are changing the way things are done in business, innovation and their communities.

An assistant professor in the Department of Biochemistry and Biomedical Sciences, the 36-year-old has earned international recognition for using artificial intelligence (AI) to discover new antibiotics and tackle antimicrobial resistance, one of the world’s most pressing public health threats. His research has attracted global attention, including recognition from The New York Times, which identified his work as one of the most significant scientific advances of 2023.

But while Stokes is helping redefine how new medicines are discovered, he’s equally focused on what happens after discovery.

What is antimicrobial resistance (AMR)?

Jon Stokes, assistant professor in the Department of Biochemistry and Biomedical Sciences at McMaster University, says AMR is a phenomenon through which antimicrobial medications — like antibiotics — stop working as intended.

Microbes like bacteria, viruses, fungi, and parasites can evolve over time to resist the medications that have long treated the infections that they cause.

Stokes calls the phenomenon “an under-discussed pandemic,” noting that, in 2019 alone, 1.3 million people died from drug-resistant infections. What’s worse, he says, is the number of AMR-related deaths is expected to balloon to 10 million per year by 2050 if drug resistance is left unchecked.

Want to learn more?

Sign up to receive future communications from McMaster University